Do you find persistent knee pain making everyday activities difficult and wonder how best to manage it over the long term? For many living with knee osteoarthritis, achieving steady, ongoing comfort is a real challenge. Temporary relief isn’t always enough; people want treatments that help maintain mobility and improve quality of life day after day. Both patients and doctors are keen to find reliable injections that offer not only immediate comfort but also longer-lasting ease. In this article, we take a close look at two popular injectable treatments—Arthrosamid and corticosteroid injections—to see how they compare when it comes to providing steadier, more sustained relief. With new advances in therapies and expert insights, knee osteoarthritis care is moving towards more personalised, patient-centred solutions.

Understanding Injectable Therapies for Knee Osteoarthritis

Knee osteoarthritis is a common condition that gradually wears down the joint, often causing pain, stiffness, and difficulty moving. It’s a major cause of reduced quality of life as people age. Managing symptoms effectively means finding treatments that ease pain while supporting the joint’s long-term health and function.

Injectable therapies have become an important tool in this approach, delivering medicine directly into the joint to target symptoms more precisely. For years, corticosteroid injections have been widely used for their powerful anti-inflammatory effect and quick pain relief. Recently, however, newer options such as Arthrosamid have begun to stand out, offering a different mechanism with the promise of steadier, longer-lasting comfort.

A recent study noted, “Arthrosamid® has been known to be safe and efficacious in knee osteoarthritis (OA) patients” (Gao et al., 2025a), highlighting growing evidence for this treatment’s role. Understanding these options helps patients and clinicians plan for sustained improvement rather than fleeting relief.

Corticosteroid Injections: What They Offer and Their Limits

Corticosteroid injections are well known for quickly easing inflammation and pain in the knee joint. By injecting steroids directly into the area, patients often notice relief within days. This rapid effect makes corticosteroids a popular choice, especially when pain flares suddenly.

However, their benefits can be short-lived. Relief often lasts only several weeks to a few months before symptoms may return, leading to the need for repeat treatments. Frequent corticosteroid injections raise concerns because they might harm cartilage over time, possibly speeding up joint damage.

Professional bodies such as the British Orthopaedic Society advise cautious use of steroids, recommending they be part of a carefully managed treatment plan to balance the benefits against potential risks. So while corticosteroids are valuable, they’re best used thoughtfully, with attention to both short- and long-term joint health.

Arthrosamid: A New Option for Longer-Lasting Comfort

Arthrosamid offers a fresh approach. It’s a polymer-based hydrogel injected into the joint that acts like a cushion, improving the joint environment mechanically rather than just reducing inflammation. This means it can ease pain by making movement smoother without the risk of cartilage damage seen with steroids.

There’s increasing interest in who benefits most from Arthrosamid. As one study points out, “literature surrounding which patients would incur the most benefit from Arthrosamid is limited” (Gao et al., 2025a). The same research highlights the need to “identify which patient factors would allow Arthrosamid to provide the most clinical benefit in a knee OA patient.” This means researchers and clinicians are working to personalise treatment based on patient characteristics for best results.

Thanks to its non-damaging profile and potential to provide steadier, longer-lasting relief, Arthrosamid is becoming an attractive option for many patients. Still, further research is underway to fully understand who gains the most and how to best use this treatment.

Why Skilled Clinicians Matter and Best Practice Standards

The success of any injection depends greatly on the clinician delivering it. Experts like Professor Paul Lee—a recognised cartilage specialist and ambassador for the Royal College of Surgeons of Edinburgh—are at the forefront of applying these treatments safely and effectively.

Clinics such as MSK Doctors emphasise patient-focused care and teamwork across various disciplines to support tailored recovery. Experienced practitioners are skilled in using innovative injections like Arthrosamid and advanced joint techniques, including uncemented implants when suitable, ensuring patients get the best possible outcome.

By following established national guidelines and combining innovation with traditional expertise, these clinicians help patients achieve not just temporary relief, but sustained joint health and mobility.

Choosing the Right Injection: Making an Informed Choice

Choosing between Arthrosamid and corticosteroid injections is not a one-size-fits-all decision. Corticosteroids are excellent when fast relief is needed, such as during sudden flare-ups, while Arthrosamid may offer steadier comfort that helps maintain everyday function over the months that follow.

It’s important to tailor the choice to the individual. Clinical studies remind us that “patient factors would allow Arthrosamid to provide the most clinical benefit in a knee OA patient” (Gao et al., 2025a), highlighting that characteristics like age, health status and the severity of osteoarthritis influence outcomes.

Discussing options with healthcare professionals ensures treatments are matched to lifestyle and goals, helping patients better manage their condition day to day. Looking forward, advances in orthopaedics promise even more refined injection therapies. Working closely with expert clinicians will be key to unlocking the full benefits of these emerging solutions for steady, long-lasting comfort.

In summary, injectable therapies for knee osteoarthritis are evolving. Understanding the differences between options like corticosteroids and Arthrosamid, combined with expert care and personalised decision-making, can enable patients to move with less pain and more confidence every day.

References

• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma. https://doi.org/10.1016/j.jcot.2025.103136
• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. (2025a). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648